Wen‐Hsien Liu
- Immunology top 10%
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
-
- CAR-T cell therapy research 2
-
- Seaweed-derived Bioactive Compounds 2
Wen‐Hsien Liu
28 papers receiving 834 citations
Peers
Comparison fields: 5 of 97
- Immunology 372
- Cancer Research 253
- Molecular Biology 416
- Oncology 116
- Aquatic Science 24
Countries citing papers authored by Wen‐Hsien Liu
This map shows the geographic impact of Wen‐Hsien Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hsien Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hsien Liu more than expected).
Fields of papers citing papers by Wen‐Hsien Liu
This network shows the impact of papers produced by Wen‐Hsien Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hsien Liu. The network helps show where Wen‐Hsien Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen‐Hsien Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 81 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 16 | |
| 13 | 2021 | 32 | |
| 14 | 2021 | 9 | |
| 15 | 2016 | 52 | |
| 16 | 2015 | 47 | |
| 17 | 2013 | 113 | |
| 18 | 2013 | 144 | |
| 19 | 2007 | 50 | |
| 20 | 1997 | 67 |
About Wen‐Hsien Liu
Wen‐Hsien Liu is a scholar working on Immunology, Cancer Research and Toxicology, having authored 30 papers that have together received 844 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (9 papers), MicroRNA in disease regulation (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer-related molecular mechanisms research (3 papers), CAR-T cell therapy research (2 papers), Seaweed-derived Bioactive Compounds (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Immunology (372 citations), Cancer Research (253 citations) and Molecular Biology (416 citations). Wen‐Hsien Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ming‐Zong Lai, Changchun Xiao, Hyun Yong Jin, Seung Goo Kang, Jovan Shepherd, Rui Chang, Mingye Feng, Si‐Tse Jiang, Nengming Xiao and John R. Teijaro. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.